WAYNE, Pa.--(BUSINESS WIRE)--Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced the start of enrollment in the Tack Optimized Balloon Angioplasty Below the Knee (TOBA-BTK) study. This multi-center pilot study will gather data supporting the safety and performance of the Tack-It Endovascular System™ in subjects with Critical Limb Ischemia (CLI) due to vascular disease below the knee. A previously enrolled and ongoing clinical trial recruited patients with claudication due to vascular disease for the above the knee indication.
Help employers find you! Check out all the jobs and post your resume.
